Macrogenics (MGNX) Net Equity Issued and Repurchased (2012 - 2023)

Macrogenics (MGNX) has 11 years of Net Equity Issued and Repurchased data on file, last reported at $616000.0 in Q1 2023.

• On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $616000.0 in Q1 2023; TTM through Dec 2023 was $616000.0, a 43.23% decrease from a year earlier, with the FY2023 full-year figure at $616000.0, down 43.23% from the prior year.
• Net Equity Issued and Repurchased for Q1 2023 stood at $616000.0, down from $1.1 million in the prior quarter.
• Over the last five years, Net Equity Issued and Repurchased for MGNX reached as high as $118.7 million in Q1 2019 and fell as low as -$38000.0 in Q4 2020.
• Historically, Net Equity Issued and Repurchased has averaged $51.1 million across 5 years, with a median of $46.8 million in 2020.
• On a YoY basis, Net Equity Issued and Repurchased climbed as much as 73.48% in 2021 and fell as far as 73.48% in 2021.
• Year by year, Net Equity Issued and Repurchased stood at $118.7 million in 2019, then plunged by 100.03% to -$38000.0 in 2020, then jumped by 51726.32% to $19.6 million in 2021, then plunged by 94.47% to $1.1 million in 2022, then plunged by 43.23% to $616000.0 in 2023.
• Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $616000.0 in Q1 2023, $1.1 million in Q4 2022, and $19.6 million in Q3 2021.